Paeoniflorin, a Natural Product With Multiple Targets in Liver Diseases—A Mini Review

Paeoniflorin, a Natural Product With Multiple Targets in Liver Diseases—A Mini Review

Paeoniflorin is derived from Paeonia suffruticosa Andr., Paeonia lactiflora Pall., or Paeonia veitchii Lynch and has been used in traditional medical applications for more than 2,000 years. Paeoniflorin is a monoterpenoid glycoside with various effects on liver diseases. Recent studies have revealed...

Full description

Bibliographic Details
Main Authors:	Xiao Ma, Wenwen Zhang, Yinxiao Jiang, Jianxia Wen, Shizhang Wei, Yanling Zhao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-04-01
Series:	Frontiers in Pharmacology
Subjects:	paeoniflorin hepatic protection cholestasis liver fibrosis nonalcoholic fatty liver disease hepatocellular carcinoma
Online Access:	https://www.frontiersin.org/article/10.3389/fphar.2020.00531/full

Similar Items

Mechanism of Paeoniflorin in the Treatment of Bile Duct Ligation-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology
by: Shizhang Wei, et al.
Published: (2020-10-01)

Paeoniflorin regulates macrophage activation in dimethylnitrosamine-induced liver fibrosis in rats
by: Chen Xiaorong, et al.
Published: (2012-12-01)

Mechanism of Paeoniflorin on ANIT-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology
by: Lisheng Chen, et al.
Published: (2021-08-01)

Comparison of liver enzymes level and sonographic findings value with liver biopsy findings in nonalcoholic fatty liver disease patients
by: Mahsa Khodadoostan, et al.
Published: (2016-01-01)

Recent update: Nonalcoholic steatohepatitis
by: Vivek Hande, et al.
Published: (2018-01-01)

The Natural Course of Non-Alcoholic Fatty Liver Disease
by: Luis Calzadilla Bertot, et al.
Published: (2016-05-01)

Liver Fibrosis: A Clinical Update
by: Lindsey C. Shipley, et al.
Published: (2019-05-01)

Liver Fibrogenesis in Nonalcoholic Steatohepatitis
by: Xiong eMa
Published: (2012-07-01)

Preventive and therapeutic role of Tanshinone ⅡA in hepatology
by: Miao-Juan Shi, et al.
Published: (2019-04-01)

Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
by: Gwyneth Shook Ting Soon, et al.
Published: (2021-01-01)

Mechanism of Hydrophobic Bile Acid-Induced Hepatocyte Injury and Drug Discovery
by: Shizhang Wei, et al.
Published: (2020-07-01)

The Role of Long Non-Coding RNAs (lncRNAs) in the Development and Progression of Fibrosis Associated with Nonalcoholic Fatty Liver Disease (NAFLD)
by: Amanda Hanson, et al.
Published: (2018-08-01)

Non-invasive assessment of liver fibrosis with transient elastography (FibroScan®): applying the cut-offs of M probe to XL probe
by: Grace Lai-Hung Wong, et al.
Published: (2013-07-01)

Development and validation of a simple risk model to predict major cancers for patients with nonalcoholic fatty liver disease
by: Zihan Wei, et al.
Published: (2020-02-01)

Animal Models of Nonalcoholic Fatty Liver Disease—A Starter’s Guide
by: Mikhaïl A. Van Herck, et al.
Published: (2017-09-01)

FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic
by: Yoshio Sumida, et al.
Published: (2021-02-01)

The FIB-4 Index Is a Useful Predictor for the Development of Hepatocellular Carcinoma in Patients with Coexisting Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B
by: Minah Kim, et al.
Published: (2021-05-01)

The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma
by: Tomomi Kogiso, et al.
Published: (2021-01-01)

Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
by: Gwyneth Soon, et al.
Published: (2021-01-01)

Treatment Options in Non-alcoholic Fatty Liver Disease
by: Won Kim
Published: (2017-06-01)

Telomeres, NAFLD and Chronic Liver Disease
by: Benedetta Donati, et al.
Published: (2016-03-01)

CHOP deficiency attenuates steatohepatitis, fibrosis and carcinogenesis in mice fed an MCD diet
by: Toriguchi, Kan
Published: (2014)

Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease
by: Chan, W.-K, et al.
Published: (2022)

Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey
by: Helma P. Cotrim, et al.
Published: (2016-05-01)

Novel Insights into the Genetic Landscape of Nonalcoholic Fatty Liver Disease
by: Alice Emma Taliento, et al.
Published: (2019-08-01)

Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort Study
by: I. Yu. Pirogova, et al.
Published: (2018-09-01)

Blood lead level is associated with advanced liver fibrosis in patients with non-alcoholic fatty liver disease: A nationwide survey (NHANES 2011–2016)
by: Debashis Reja, et al.
Published: (2020-07-01)

AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis
by: Aurora Loaeza-del-Castillo, et al.
Published: (2008-10-01)

Carcinogenesis and Metastasis in Liver: Cell Physiological Basis
by: Anna Rossetto, et al.
Published: (2019-11-01)

The Gut Microbiota, Tumorigenesis, and Liver Diseases
by: Guishuai Lv, et al.
Published: (2017-02-01)

Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma
by: Marta B. Afonso, et al.
Published: (2016-03-01)

The efficacy of aspartate aminotransferase-to-platelet ratio index for assessing hepatic fibrosis in childhood nonalcoholic steatohepatitis for medical practice
by: Earl Kim, et al.
Published: (2013-01-01)

Overexpression of the Vitronectin V10 Subunit in Patients with Nonalcoholic Steatohepatitis: Implications for Noninvasive Diagnosis of NASH
by: Maria Del Ben, et al.
Published: (2018-02-01)

The role of zinc in the prevention and treatment of nonalcoholic fatty liver disease
by: Mary Barbara, et al.
Published: (2021-09-01)

Prevalence of type 2 diabetes mellitus and chronic liver disease: A retrospective study of the association of two increasingly common diseases in Mexico
by: Ramón Arturo Kobashi-Margáin, et al.
Published: (2010-07-01)

Effect of Korean Red Ginseng in chronic liver disease
by: Tae Young Park, et al.
Published: (2017-10-01)

The Appropriate Opportunity for Evaluating Liver Fibrosis by Using the FIB-4 Index in Patients with Nonalcoholic Fatty Liver Disease in Japan
by: Yuya Seko, et al.
Published: (2020-10-01)

Noninvasive diagnosis of liver fibrosis in patients with nonalcoholic fatty liver disease
by: Yu.M. Stepanov, et al.
Published: (2017-09-01)

The role of cGAS-STING signalling in liver diseasesKey points
by: Ruihan Chen, et al.
Published: (2021-10-01)

Insulin-Like Growth Factor (IGF) System in Liver Diseases
by: Agnieszka Adamek, et al.
Published: (2018-04-01)